In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Dr. F. Stephen Hodi led a study showing more than one-third of advanced melanoma patients treated with the immunotherapy drug Opdivo have survived at least five years.

Tags: Melanoma

  • Dr. Rachel Freedman comments on a study showing older black women with human epidermal growth factor receptor 2 (HER2)–positive breast cancer are less likely than their white peers to receive targeted therapy.


Tags: BreastCancer

  • Dr. David A. Williams, president of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, comments on why pediatric cancers should be a priority for research funds.

Tags: ChildhoodCancer

  • Drs. Kornelia Polyak, Tari King and Jennifer Ligibel are new leaders in breast cancer research and advocacy for the Komen Scholars international advisory group.


Tags: BreastCancer

  • Dr. Geoffrey Oxnard led a study showing how a simple blood test can help treat patients with certain lung cancers.

Tags: LungCancer

  • Dr. Laurie Glimcher, set to become the next CEO of Dana-Farber, was chosen as one of two dozen leading cancer researchers to advise Vice President Joe Biden’s cancer moonshot initiative.

Tags: Appointments

  • Dana-Farber nutritionist Stacy Kennedy talks about cancer patients balancing the advantage of taking fish oil with the potential risks.

Tags: Nutrition

  • Dr. Jennifer Ligibel talks about how healthy behaviors may be powerful tools in preventing cancer recurrence.

Tags: BreastCancer

  • Dr. Jeffrey Meyerhardt and Dr. Charles Fuchs accepted a check from the 9-year old son of a Dana-Farber patient who raised money to fund colon cancer research.

Tags: ColonCancer

  • Dr. Mehra Golshan and researcher Shoshana Rosenberg comment on the rise in the number of women who have cancer in just one breast, but choose to have both breasts surgically removed.

Tags: BreastCancer

Showing 11-20 of 660 items